Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Camille V. EdwardsDepartment of Medicine, Harlem Hospital Center, New York, NY, USA,

Julia GouldDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA,

Arielle L. LangerDivision of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA,

Markus MaparaDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA,

Jai RadhakrishnanDivision of Nephrology and

Mathew S. MaurerDivision of Cardiology, Columbia University Medical Center, New York, NY, USA, and

Shahzad RazaDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA,

John G. MearsDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA,

Jonathan WallGraduate School of Medicine, University of Tennessee, Knoxville, TN, USA

Alan SolomonGraduate School of Medicine, University of Tennessee, Knoxville, TN, USA

Suzanne LentzschDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA, Correspondence[email protected]

show all

"Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis." Amyloid, 24(sup1), pp. 58–59

Declaration of interest

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Information for

Open access

Opportunities

Help and information

Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature